Amphastar Pharmaceuticals (AMPH) Gross Profit Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) Gross Profit Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | 7.62% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 4.71% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -7.64% |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn | 12.55% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn | -9.13% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | 24.80% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | 0.95% |
| 10 | Amphastar Pharmaceuticals | 872.45 Mn | 701.31 Mn | 70.32 Mn | -1.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.61% |
| Dec 31, 2025 | 6.38% |
| Sep 30, 2025 | 19.02% |
| Jun 30, 2025 | 10.93% |
| Mar 31, 2025 | 15.16% |
| Dec 31, 2024 | 15.50% |
| Sep 30, 2024 | 25.82% |
| Jun 30, 2024 | 26.18% |
| Mar 31, 2024 | 26.09% |
| Dec 31, 2023 | 37.69% |
| Sep 30, 2023 | 43.73% |
| Jun 30, 2023 | 29.91% |
| Mar 31, 2023 | 26.10% |
| Dec 31, 2022 | 28.70% |
| Sep 30, 2022 | 18.40% |
| Jun 30, 2022 | 25.07% |
| Mar 31, 2022 | 21.79% |
| Dec 31, 2021 | 17.47% |
| Sep 30, 2021 | 20.49% |
| Jun 30, 2021 | 22.04% |